1. Junctional zone thickness in young nulliparous women according to menstrual cycle and hormonal contraception use 
Liesbeth Johannes Meylaerts, Leen Wijnen, Martijn Grieten, Yvan Palmers, Willem Ombelet, Marjan Vandersteen 
Reproductive BioMedicine Online 
Volume 34, Issue 2, Pages (February 2017)
DOI: /j.rbmo
Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

2. Figure 1
Uterine measurement parameters. (A and B) On the T2-weighted turbo spin echo (T2 TSE) sagittal magnetic resonance image after buscopan injection without fat suppression, junctional zone thickness and thickness of the outer myometrium [A] were measured at the level of the isthmus (I), the midcorpus (M) and the fundus (F) of the uterine anterior (A) and posterior (P) wall [B]. On this image, the antero-posterior size of the corpus was also determined; (C) the latero-lateral (LL) size of the corpus was measured on the coronal T2-weighted magnetic resonance image obtained before buscopan injection. AF, anterior fundal; AI, anterior isthmus; AM, anterior midcorpus; PF, posterior fundal; PI, posterior isthmus; PM, posterior midcorpus.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

3. Figure 2
Junctional zone thickness of healthy nulliparous non-users and users of hormonal contraception. The minimum, maximum and mean junctional zone thickness measurements are represented at six locations in the uterine wall, in the follicular phase (phase 1), ovulatory phase (phase 2) and luteal phase (phase 3) of non-users (group 1) and users (group 2) of hormonal contraception. *P < 0.05 between the non-users and users of hormonal contraception.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

4. Figure 3
Myometrial thickness of healthy nulliparous non-users and users of hormonal contraception. The minimum, maximum and mean myometrial thickness measurements are represented at six locations in the uterine wall, in the follicular phase (phase 1), ovulatory phase (phase 2) and luteal phase (phase 3) of non-users (group 1) and users (group 2) of hormonal contraception. *(blue): P < between the locations in the uterine wall (both anterior and posterior wall) for the non-users of hormonal contraception.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions

5. Figure 4
The ratio of junctional zone thickness versus total myometrial thickness of healthy nulliparous non-users and users of hormonal contraception. The minimum, maximum and mean ratios are represented at six locations in the uterine wall, in the follicular phase (phase 1), ovulatory phase (phase 2) and luteal phase (phase 3) of non-users (group 1) and users (group 2) of hormonal contraception. *(black): P < 0.05 between the non-users and users of hormonal contraception, *(blue): P < 0.05 between the locations in the uterine wall (both anterior and posterior wall) for the non-users of hormonal contraception.
Reproductive BioMedicine Online  , DOI: ( /j.rbmo )
Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions